Skip to main content
. 2022 Apr 1;54(10):2673–2681. doi: 10.1007/s11255-022-03178-5

Table 2.

Effect of Sharesource® on health-related quality of life

Variables With sharesource® Without sharesource® P value
KDQOL
 Symptoms/problems 77.5 ± 14.6 75.2 ± 12.9 0.53
 Effects of kidney disease 79.0 ± 17.2 74.6 ± 16.3 0.14
 Burden of kidney disease 42.5 ± 23.0 37.9 ± 21.2 0.09
 Work status 66.7 ± 40.8 66.7 ± 36.2 1
 Cognitive function 92.0 ± 9.2 92.0 ± 8.8 1
 Quality of social interaction 87.8 ± 9.7 89.8 ± 14.7 0.57
 Sleep 55.4 ± 21.9 56.7 ± 16.3 0.74
 Social support 76.1 ± 28.0 77.2 ± 26.4 0.79
 Satisfaction for care 84.4 ± 13.3 84.4 ± 13.3 1
 Encouragement from staff 81.7 ± 21.1 76.7 ± 24.9 0.32
 KDCS 74.3 ± 9.7 73.1 ± 10.8 0.48
SF-36
 Physical functioning 70.3 ± 21.3 64.3 ± 26.2 0.05
 Physical role functioning 69.2 ± 31.3 61.3 ± 28.7 0.25
 Body pain 63.7 ± 26.4 57.1 ± 23.1 0.17
 General health 49.0 ± 23.2 39.5 ± 22.5  <0.001
 Vitality 51.7 ± 21.3 45.0 ± 24.6  <0.05
 Social functioning 65.8 ± 32.9 53.3 ± 37.9 0.13
 Emotional role functioning 76.1 ± 31.2 72.2 ± 33.3 0.59
 Mental health 75.3 ± 18.8 72.7 ± 18.7 0.30
 PCS 37.9 ± 15.2 34.1 ± 14.5 0.09
 MCS 50.9 ± 10.2 48.5 ± 8.5 0.09
 RCS 43.7 ± 15.7 41.3 ± 17.9 0.51

KDQOL Kidney Disease Quality of Life, KDCS kidney disease component summary, SF-36 Medical Outcomes Study 36-Item-Short Form Health Survey MOS, PCS physical component summary, MCS mental component summary, RCS role/social component summary